Drug information provided by: Merative, Micromedex®
Fluoroestradiol F 18 injection is used together with biopsy to help detect estrogen receptor (ER)-positive lesions in patients with recurrent or metastatic breast cancer (cancer that keeps coming back or has spread to the other parts of the body). It is used in a procedure called positron emission tomography (PET) scan to help your doctor see an image of your breast. This medicine is not used to detect other types of lesion receptors, including human epidermal growth factor receptor 2 (HER2) and progesterone receptor (PR).
Fluoroestradiol F 18 is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain diseases or to study the function of the body's organs.
This medicine is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!